 HemOncToday | Low-dose rituximab plus steroids demonstrated safety, efficacy in autoimmune ... HemOncToday The combination of low-dose rituximab and steroids was linked to overall response rates of more than 80% in a cohort of patients with autoimmune hemolytic anemia, according to recent results. Low-dose rituximab (Rituxan, Genentech/Idec Pharmaceuticals) ... |
